Abstract-Microfluidics-based biochips are revolutionizing highthroughput sequencing, parallel immunoassays, clinical diagnostics, and drug discovery. These devices enable the precise control of nanoliter volumes of biochemical samples and reagents. Compared to conventional laboratory procedures, which are cumbersome and expensive, miniaturized biochips offer the advantages of higher sensitivity, lower cost due to smaller sample and reagent volumes, system integration, and less likelihood of human error. This keynote paper provides an overview of droplet-based "digital" microfluidics and outlines emerging computer-aided design (CAD) tools for the automated synthesis and optimization of biochips from bioassay protocols.
INTRODUCTION
Advances in digital microfluidics have led to the promise of miniaturized biochips for applications such as immunoassays for point-of-care medical diagnostics, DNA sequencing, and the detection of airborne particulate matter [1] . These devices enable the precise control of nanoliter droplets of biochemical samples and reagents, and integrated circuit (IC) technology can be used to transport and process "biochemical payload" in the form of tiny droplets. Compared to conventional laboratory procedures, which are cumbersome and expensive, miniaturized biochips offer the advantages of higher sensitivity, lower cost, faster results, and less likelihood of human error.
However, continued growth in this emerging field depends on advances in chip/system integration. In particular, design methods are needed to ensure that biochips are as versatile as the macro-labs that they are intended to replace.
This keynote paper is focused on droplet-based "digital" microfluidic biochips and associated design automation tools. The digital microfluidics platform offers the flexibility of dynamic reconfigurability and software-based control of multifunctional biochips. Automated design techniques allow biochip users to concentrate on the development of nanoscale bioassays, leaving chip optimization and implementation details to design-automation tools. Details about the design and test techniques outlined in this paper can be found in the references.
II. TECHNOLOGY PLATFORMS
Early biochips were based on the concept of a DNA microarray, which is a piece of glass, plastic or silicon substrate on which pieces of DNA, i.e., probes, have been affixed. The basic idea of a microfluidic biochip is to integrate all necessary functions for biochemical analysis using microfluidics technology. Integrated functions include assay operations, detection, and sample preparation.
A digital microfluidic biochip utilizes electrowetting on dielectric to manipulate nanoliter droplets containing biological samples on a two-dimensional electrode array [1] . A unit cell in the array includes a pair of electrodes that acts as two parallel plates. The bottom plate contains a patterned array of individually controlled electrodes, and the top plate is coated with a continuous ground electrode. A droplet rests on a hydrophobic surface over an electrode. It is moved by applying a control voltage to an electrode adjacent to the droplet and, at the same time, deactivating the electrode just under the droplet. Using interfacial tension gradients, droplets can be moved to any location on a two-dimensional array.
III. SYNTHESIS METHODS
We next examine CAD problems related to biochip synthesis [3] [4] [5] [6] [7] [8] [9] . Optimization goals here include the minimization of assay completion time, minimization of chip area, and higher defect tolerance. One of the first published methods for biochip synthesis decoupled high-level synthesis from physical design [2] . Architectural-level synthesis for microfluidic biochips can be viewed as the problem of scheduling assay functions and binding them to a given number of resources so as to maximize parallelism, thereby decreasing response time. Geometry-level synthesis (physical design) addresses the placement of resources and the routing of droplets to satisfy objectives such as area or throughput [3] .
A key problem in the geometry-level synthesis of biochips is the placement of microfluidic modules such as different types of mixers and storage units. Since digital microfluidicsbased biochips enable dynamic reconfiguration of the microfluidic array during run-time, they allow the placement of different modules on the same location during different time intervals. In follow-up work, [4] proposed a unified system-level synthesis method to link these two steps. Efficient reconfiguration techniques have also been developed to bypass faulty unit cells in the microfluidic array.
Droplet routing is a key problem in biochip physical design. The dynamic reconfigurability inherent in digital microfluidics allows different droplet routes to share cells on the microfluidic array during different time intervals. In this sense, the routes in microfluidic biochips can be viewed as virtual routes, which make droplet routing different from the classical VLSI wire routing problem. The first method for droplet routing in biochips was published in [5] . In [6] , a method was proposed a method to incorporate droplet routability in the synthesis flow.
Electrode addressing is also an important problem in biochip design. It refers to the manner in which electrodes are connected to and controlled by input pins. An arraypartitioning-based pin-constrained design method of digital microfluidic biochips proposed in [7] . This method uses array partitioning and careful pin assignment to reduce the number of control pins. The key idea is to "virtually" partition the array into regions. The partitioning criterion here is to ensure that at most one droplet is included in each partition.
An alternative design method based on a cross-reference driving scheme is presented in [8] . This method allows control of an N M grid array with only N+M control pins. However, due to electrode interference, this design cannot handle the simultaneous movement of more than two droplets.
A solution based on destination-cell categorization has been proposed to tackle the above problem. The key idea is to group the droplet movements according to their destination cells. A group consists of droplets whose destination cells share the same column or row. The problem of finding the minimum number of groups can be directly mapped to the problem of determining a minimal clique partition from graph theory.
A broadcast-addressing based design technique for pinconstrained and multi-functional biochips has been developed in [9] . To execute a specific bioassay, routing and scheduling information must be stored in the form of electrode activation sequences, where each bit representing the status of the electrode at a specific time-step. The status can be either "1" (activate), "0" (deactivate) or "x" (don't-care). Each electrode activation sequence contains several don't-care terms, which can be replaced by "1" or "0". If two sequences can be made identical by careful replacing these don't-care terms with "0" or "1", they are referred to as compatible sequences. Compatible sequences can be generated from a single signal source. The number of control pins can be reduced by connecting together electrodes with mutually-compatible activation sequences, and addressing them using a single control pin.
IV. TESTING
An electrical test method for digital microfluidic biochips has been presented, whereby faults can be detected by controlling and tracking droplet motion electrically. The key idea is to check for capacitiance change at a sink electrode [10] .
A drawback of the above "structural" test method is that it is focus only on physical defects, and it overlooks module functionality. A defect-free reservoir may result in large volume variations when droplets are dispensed from it. A splitter composed of three defect-free electrodes may split a big droplet into two droplets with significantly unbalanced volumes. These phenomena, referred to as malfunctions, are not the result of electrode defects. Instead, they are activated only for certain patterns of droplet movement or fluidic operations.
Functional testing involves test procedures to check whether groups of cells can be used to perform certain operations, e.g., droplet mixing and splitting. For the test of a specific operation, the corresponding patterns of droplet movement are carried out on the target cluster of cells. If a target cell cluster fails the test, e.g., the mixing test, we label it as a malfunctioning cluster. As in the case of structural testing, fault models must be developed for functional testing. Malfunctions in fluidic operations need to be identified and included in the list of faults.
Functional test methods to detect the defects and malfunctions have recently been developed. In particular, dispensing test, mixing test, splitting test, and capacitive sensing test have been described in [11] to address the corresponding malfunctions.
